DrukMed App

Announcements & Notifications

Vacancy Announcement-Reschedule

February 3rd, 2021

With reference to the postponement of the date of application submission No. DRA/D4b/16-PRO(Adv)2021/444 dated December 30, 2020, the Drug Regulatory Authority is pleased to reschedule the last date for submission of application for the post of Chief Regulatory Officer, Post Marketing Control Division to 9th February 2021. However, those who have already submitted the application […]

» read more

Press Brief On Emergency Use Authorization for Covishield

January 23rd, 2021

The Drug Regulatory Authority (DRA) on 21 January 2021 granted Emergency Use Authorization for Covishield™ manufactured by Serum Institute of India. The authorization was based on recommendation of the Drugs Technical Advisory Committee (DTAC) and approval ofHon’ble Chairperson, Bhutan Medicines Board. DRA has reviewed the data of the National Regulatory Authority for AstraZeneca/Oxford vaccine and […]

» read more

Regulatory Notification on Emergency Use Authorization procedure and conditions for Deployment of COVID-19 Vaccines

January 17th, 2021

Drug Regulatory Authority (DRA) is pleased to issue a guidance document on Emergency Use Authorization procedure and conditions for Deployment of COVID-19 Vaccines. This procedure is effective from 10 January 2021. The decision to grant the Emergency Use Authorization (EUA) of COVID-19 vaccines is contingent to fulfilling the following: The COVID-19 vaccine should be listed […]

» read more
View More Announcements

Novel Coronavirus (COVID-19) in Bhutan

Coronavirus disease (COVID-19) Pandemic

 
 
Citizen Satisfaction Survey